The latest precision medicine news

NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers

Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE–(BUSINESS WIRE)–NanoString...read more

Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)

Next generation sequencing offers more comprehensive data on more commonly inherited health conditions LEHI, Utah & SAN FRANCISCO–(BUSINESS WIRE)–Ancestry®, the global leader in family history and...read more

Sema4 Closes $121 Million Series C Led by BlackRock

Sema4’s post-money valuation exceeds $1 billion STAMFORD, CT — July 28, 2020 — Sema4, a patient-centered health intelligence company, today announced that funds managed by BlackRock led its oversubscribed Series C...read more

Life of a Clinical Geneticist: Dealing Often With Heartless Bureaucracy

Recently I got a glimpse of life as a clinical geneticist when I spoke with Dr. Tom Morgan from Vanderbilt University School of Medicine. So many of us across the industry are excited about the many advancements and the...read more

Illumina Acquires Enancio’s Compression Software

Reduces genomic data storage and transfer costs associated with the data deluge 14 July 2020 In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems...read more

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™...read more

Intermountain Healthcare Implements DeepThink Health’s Precision Intelligence Solutions to Manage its Molecular Tumor Board

RICHMOND, Calif., July 7, 2020 /PRNewswire/ — DeepThink Health, Inc., a technology innovator in advanced analytics and artificial intelligence for precision medicine, announced today that Intermountain...read more

Genomics England launches next-generation research platform central to UK COVID-19 response

British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments Genomics England (GEL) has today launched a next-generation genomic...read more

Bluebee’s coherent data strategy set to unify Illumina’s data analytics products

This month’s attention-grabbing headlines in the field of genomics, genetics, and precision medicine can undoubtedly be attributed to the acquisition of Bluebee by Illumina. I spoke with Hans Cobben, CEO of Bluebee and...read more

WuXi NextCODE Restructures and Becomes Genuity Science

BOSTON, June 23, 2020 /PRNewswire/ — WuXi NextCODE today announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking...read more

Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

Combination to bring germline and somatic testing, liquid biopsy and tissue genomic profiling onto a single platform to offer patients a full suite of cancer testing for risk, therapy optimization and personalized...read more

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale

Enabling clinical, translational research, population genomics, and biopharma customer markets SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret...read more

Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care

Acquisition will expand Foundation Medicine’s multiomics capabilities, including the adoption of DNA methylation to evaluate cancer progression in broader patient populations CAMBRIDGE, Mass.–(BUSINESS...read more

DNAnexus Completes $100 Million Financing

Supporting the company’s global biomedical data and informatics platform and expansion in clinical diagnostics, pharmaceuticals, and medical centers MOUNTAIN VIEW, CA – June 9, 2020 | DNAnexus, Inc., the leading...read more

Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy

Epigenetics company Base Genomics launches, based on a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford The technology, TAPS (TET...read more

The Interface of Genomic Information with the Electronic Health Record: an ACMG Points to Consider Statement

Bethesda, MD – June 1, 2020 │Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become...read more

QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients

Hilden, Germany, and Germantown, Maryland, May 28, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of novel solutions enabling faster, better analysis of genomic variations...read more

Syapse Announces $30M Financing to Advance the Use of Real-World Evidence

SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — Syapse, today announced $30 million in new equity funding to accelerate the creation and use of real-world evidence in oncology. The financing was led by Revelation...read more

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing BOSTON, May 28, 2020 /PRNewswire/ — Today, Ginkgo Bioworks is announcing...read more

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with...read more

Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome

Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a...read more

TruGenomix Partners with BlueBee to Create the Next Generation Behavioral Science Data Ecosystem

ROCKVILLE, Maryland and SAN MATEO, California, May 20, 2020 /PRNewswire/ — The unprecedented COVID-19 crisis has unleashed global emotional trauma that is rapidly evolving into a mental health...read more

New partnership to sequence human genomes in the fight against coronavirus

Genetic susceptibility to coronavirus to be tested in ground-breaking nationwide study Genomes of thousands of patients with coronavirus will be sequenced to understand how a person’s genetic makeup could influence how...read more

The Role of the Human Gut Microbiome in Type 1 Diabetes

The human microbiome – which is the sum of all the microorganism that live in conjunction with the human body – includes eukaryotes, archaea, bacteria as well as the viruses and phages that infect them. Not...read more

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

Regeneron Genetics Center will sequence 450,000 informed and consented patients Sequencing data will be paired with de-identified health records to aid in genomic medicine, drug discovery and personalized medicine...read more

GRAIL Announces $390 Million Series D Financing

MENLO PARK, Calif., May 6, 2020 – GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round. New investors including Public...read more

Lifebit Closes $7.5M Series A Round to Accelerate Global Market Expansion

LONDON, U.K., April 30, 2020 – Lifebit Biotech, developer of bioinformatics and cognitive software solutions, announced it closed its Series A funding round of $7.5 million (£6 million) led by Idinvest Partners, to fuel...read more

Genalyte Expands Laboratory Services Offering with Acquisition of BaseHealth

Acquisition Blends Rapid Diagnostic Services with Cutting-edge Healthcare Analytics to Better Deliver Real-Time Value to Care Givers and Patients SAN DIEGO, April 25, 2020 /PRNewswire/ — Genalyte, a...read more

Gene Editing Revamped with CRISPR Prime Editor – Result Is A High Efficiency, More Precise Gene Editor With Versatile Editing Capabilities And Lower Off-Target Effects

In October 2018 we published a blog (CRISPR Base Editors: An Upgrade for Treatment of Genetic Disease) describing some of the concerns surrounding the use of the CRISPR technology, and highlighting a relatively new...read more

Real World Evidence is not simply a buzzword anymore in our fast-paced world of health technology

Over the last several years, various technology experts have been discussing how the impact of big data, machine learning, and artificial intelligence will affect our daily lives – from what we buy online to how...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.